Hydromorphone is Noninferior to Dexamethasone as an Adjuvant to Ropivacaine for Transversus Abdominis Plane Block After Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind Trial
Journal of Pain Research · 2026-03 · Volume 19 · 1-10
DOI: 10.2147/jpr.s581520 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pain Research, 2026-03. Verfasst von Lin Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Peking University Shougang Hospital, Beijing, People's Republic of China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Peking University Shougang Hospital, Beijing, People's Republic of China.
ORCID-Profile: Lin Zhao, Qi An, Zhenggang Guo
Zitieren
APA
Zhao, L., Wang, Y., Guo, Q., An, Q., Wu, M., Fan, C., & Guo, Z. (2026). Hydromorphone is Noninferior to Dexamethasone as an Adjuvant to Ropivacaine for Transversus Abdominis Plane Block After Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind Trial. Journal of Pain Research, Volume 19, 1-10. https://doi.org/10.2147/jpr.s581520
Vancouver
Zhao L, Wang Y, Guo Q, An Q, Wu M, Fan C, et al. Hydromorphone is Noninferior to Dexamethasone as an Adjuvant to Ropivacaine for Transversus Abdominis Plane Block After Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind Trial. Journal of Pain Research. 2026;Volume 19:1-10. doi:10.2147/jpr.s581520
BibTeX
@article{Zhao2026,
author = {Zhao, Lin and Wang, Ye and Guo, Qianqian and An, Qi and Wu, Meng and Fan, Chunling and Guo, Zhenggang},
title = {Hydromorphone is Noninferior to Dexamethasone as an Adjuvant to Ropivacaine for Transversus Abdominis Plane Block After Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind Trial},
journal = {Journal of Pain Research},
year = {2026},
volume = {Volume 19},
pages = {1--10},
doi = {10.2147/jpr.s581520}
}
EUVIMED